Combining PARP Inhibition & Androgen Receptor-Signaling Inhibition Improves Survival in HRR-Deficient mCRPC
Talazoparib added to enzalutamide significantly improved survival and preserved QOL in men with...
Read More
Author: Rebecca Shover
What Can Real-World Evidence Teach Us About Atezolizumab Plus Bevacizumab in HCC?
Therapy with atezolizumab and bevacizumab improved recurrence-free survival in patients with...
Read More
IMbrave050: Adjuvant Atezolizumab Plus Bevacizumab Provides Landmark Recurrence-Free Survival for HCC
Adjuvant therapy with atezolizumab and bevacizumab improved recurrence-free survival in patients...
Read More
Cortical Excitation/Inhibition Imbalance Has Predictive Value in MS
In MS, a lower cortical imbalance between excitation and inhibition may serve as a predictive...
Read More
Dr. MedLaw: Courts and End-of-Life Issues
Although judges will often claim, as John Roberts famously did, that they “only call balls and...
Read More
Two Dietary Interventions Lead to Improvements in MS-Related Disability
It is recommended that neurologists discuss the benefits of improving diet quality with their...
Read More
Meeting Coverage: ASCO Voices
ASCO Voices continues to be one of the most compelling sessions offered at the ASCO Annual...
Read More
Ancillary Educational Events
Ancillary events are functions held adjacent to the ASCO Annual Meeting, including, but not...
Read More
Communities of Practice
Connect with colleagues that share your passion and goals through one of ASCO’s new Communities of...
Read More
Test Your Knowledge on Early NSCLC!
A quiz based on the latest early NSCLC news and studies.
Read More
In HIV, Race-Free eGFR Equation ‘Unmasks’ High Risk for CKD Progression
The new race-free eGFR calculation reclassified a significant group of Black participants with HIV...
Read More
Why Attend CMSC
From CMSC’s Annual Meeting brochure: The Consortium of Multiple Sclerosis Centers (CMSC) has...
Read More
Quick Glance At CMSC Schedule
Take a look at CMSC’s Wednesday schedule: 8:00 am – 9:30 am ISS1 Independently...
Read More
MS Therapies Not Associated With Pregnancy Complications
A registry data analysis concluded that most disease-modifying therapies for MS are not associated...
Read More
Q&A: Can Remyelination of Axons Restore Vision in MS?
The VISIONARY-MS trial showed that CNM-Au8, an oral liquid suspension of gold nanoparticles,...
Read More
Orphan Non-Coding RNAs Have Potential for Early Identification of NSCLC
Orphan non-coding RNAs demonstrated efficacy for accurate, sensitive, and early detection of...
Read More
Gender Differences Observed in Patients With Schizophrenia Who Have TD
Female gender may offer protection against the development of cognitive impairment due to tardive...
Read More
IMPACT-TD Scale Addresses ‘Critical Need’ for Assessment Tools in TD
The IMPACT-TD scale assesses four domains of functional impairment in tardive dyskinesia (TD) and...
Read More
Advancing the Care of Advanced HCC – A Medical Oncologist’s Perspective
Physician’s Weekly recently spoke with Gentry King, MD, a medical oncologist and published author...
Read More
Advancing the Care of Advanced HCC – A Hepatologist’s Perspective
Physician’s Weekly recently spoke with Robert Gish, MD, FAASLD, a self-identified hepatologist and...
Read More